FTSE 100 testing and inspection group jumps as Swedish Equity/">Private Equity giant lifts its offer, putting pressure on the board to engage.
Shares in Intertek surged on Tuesday after Swedish private equity group EQT Partners returned with an improved Takeover proposal valuing the FTSE 100 testing, inspection and certification specialist at around £9.4 billion. The revised offer represents a meaningful increase on EQT's earlier indicative approach and intensifies the pressure on Intertek's board to enter formal negotiations, having previously rebuffed an unsolicited bid as undervaluing the Business.
The stock leapt in early trade and held the bulk of its gains throughout the session, making Intertek one of the standout performers of the day on the London market against a backdrop of broader risk aversion. The move comes at a particularly opportune moment for activist investors who had been pressing for a strategic review of the group's portfolio, while reigniting a wider debate about whether London-listed quality compounders are being structurally undervalued relative to international peers.
The terms on the table
EQT's revised proposal is understood to be pitched at a significant premium to Intertek's three-month average share price and to incorporate a partial cash-and-stub-equity structure that would allow long-standing institutional shareholders to retain exposure to the asset, should they wish. People familiar with the matter said the Swedish house had also signalled willingness to discuss limited break fees and confidentiality protections to allow Due Diligence to commence on a friendly basis.
Intertek's board has not yet provided a formal reply but is widely expected to acknowledge the improved terms publicly while seeking advice from its corporate Brokers and financial advisers. The previous approach was rejected on the grounds that it failed to reflect the long-term value of Intertek's global footprint and the recurring nature of much of its Revenue base. The new proposal narrows that gap, although bankers cautioned that further negotiation may still be required to reach a recommendable offer.
Investors appeared encouraged by the level of EQT's commitment, with several analysts noting that the bid premium implied by the new terms places Intertek among the more attractive offers seen in the UK quality industrials space this year. The deal, if completed, would rank as one of the larger take-private transactions in the London market in recent memory and would mark the latest example of overseas Capital seeking to capitalise on the relative valuation discount applied to UK-listed shares.
Why Intertek is attractive
Intertek operates in the relatively defensive, high-cash-generation arena of assurance, testing, inspection and certification, providing services to industries ranging from consumer goods and electronics through to oil and gas, life sciences and transport. The business benefits from regulatory tailwinds, long-standing customer relationships and a global laboratory network that is genuinely difficult to replicate at scale.
Recent years have seen the group accelerate its push into sustainability-related services, with new product lines aimed at Supply-chain assurance, carbon verification and environmental, social and governance reporting. These offerings sit at the intersection of regulatory tightening and corporate Demand for credible third-party attestation, and analysts expect them to underpin above-market growth over the medium term.
From EQT's perspective, the appeal of Intertek lies precisely in this combination of cash-generative core operations and clear secular growth drivers. The Swedish firm has a long track record of investing in technical services and industrial software businesses, and would be well placed to deploy operational expertise and capital into the group, particularly in expanding its higher-growth assurance and digital service lines.
Sector context
The UK quoted industrials sector has been an active hunting ground for private equity in recent years, with foreign buyers willing to look through near-term economic noise to focus on long-term operational quality. Several mid-cap industrials have been targeted or taken private over the past 18 months, and a number of larger, more international names have been the subject of unsolicited approaches.
Intertek's main listed peers, including SGS and Bureau Veritas, trade at premium multiples on continental European exchanges, a discrepancy that has long frustrated UK shareholders. Analysts argue that this valuation gap, rather than any fundamental concern about Intertek's Franchise, is precisely what is making the group such an inviting target for private equity, which sees an opportunity to bridge the gap through structural change.
The bid also lands against a broader narrative of activity in the UK take-private market. With public-market valuations under pressure and with sterling having depreciated against the dollar and the euro over recent years, foreign capital, particularly from Europe and North America, has found UK-listed Assets relatively cheap by international standards. Several recent deals in software, healthcare and engineering have already underscored the trend.
Board considerations
For Intertek's board, the considerations are now both financial and strategic. A recommendable offer would need to reflect not only the company's current cash flows but also the embedded value of its growth Options, particularly in the higher-Margin assurance segment. Independent directors will want to ensure that any deal structure is even-handed across the Shareholder base and that conditions placed on completion do not unduly transfer execution risk to shareholders.
Conversations with major shareholders will be central to the next phase. Several of Intertek's largest holders have signalled in the past that they would back the board in pushing for a higher price, but they have also acknowledged the structural valuation challenge facing UK-listed quality industrials. If EQT is able to demonstrate a sufficiently high level of conviction and to provide robust financing arrangements, the board may find it difficult to refuse continued engagement.
Governance experts pointed to a number of precedents in which initial rejections were followed by formal bid processes that ultimately led to recommended deals. The board's task in such circumstances is less to refuse outright and more to extract the best possible value from a bidder that has shown serious intent. That, Market Participants suggested, is precisely the path Intertek's directors now appear to be weighing.
Market reaction and analyst commentary
Intertek's gains were among the largest on the London exchange on Tuesday, with several brokers raising their target prices to bring them closer to the implied bid level. Some analysts went further, suggesting that the improved offer is likely to be accepted in some form and that the relevant question is now whether a competing bidder may emerge.
Rival private equity houses, sovereign Wealth funds and a small group of strategic players have all been speculatively linked with the asset over recent years. Although industry observers were quick to caution against the assumption of a bidding war, several pointed out that EQT's willingness to return with a higher offer suggests significant strategic value is on the table, increasing the probability that other suitors may take a closer look.
Equity sales desks reported strong demand from event-driven funds, while traditional long-only investors were said to be reassessing their exposure to the wider testing and inspection sector in light of the takeover dynamics. Some strategists argued that the deal, regardless of its eventual outcome, could help close the valuation discount on UK-listed quality industrials more broadly.
Implications for shareholders
For long-term Intertek shareholders, the immediate question is whether to lock in gains or hold out for a higher offer. The stock has been a relative laggard among UK industrials over the past two years, having underperformed both global peers and the broader FTSE 100 over the period. The improved bid, however, has prompted a material re-rating, and many holders may feel that the risk-reward has now turned in favour of patience.
Income investors are likely to weigh the visibility of cash flows against the certainty offered by a cash takeover. Intertek has a long-standing record of progressive dividends and consistent capital returns, but the prospect of a near-term Liquidity event with cash returns in hand will appeal to many. For institutional investors managing benchmark-aware portfolios, the implications of a delisting will need to be factored into broader allocation decisions, particularly given Intertek's previous place in several global quality and ESG-tilted indices.
Smaller, retail shareholders may benefit from clearer guidance from the company in the coming weeks. Brokers contacted by analysts emphasised the importance of reading any official board response carefully and of monitoring any formal documentation released as part of a possible bid process. Cautious wording often hides important conditions and timelines, and shareholders will need to weigh these carefully against their own circumstances.
Outlook
EQT's improved approach has propelled Intertek into the spotlight at a moment when UK take-private activity is once again gaining momentum. Whether the deal completes in its current form or is reshaped by further negotiation, or even by a rival bidder, it is now clear that the strategic conversation around Intertek has fundamentally changed. The board can no longer credibly argue that the market is simply Mispricing the business; an institutional buyer with significant capital and deep industry experience is openly putting a number on the asset.
The medium-term implications extend beyond Intertek itself. Should a deal complete, it would reinforce the narrative that high-quality UK-listed companies, particularly in industries with strong cash flows and resilient growth drivers, are vulnerable to take-private approaches. That, in turn, may further sharpen the debate about the structural competitiveness of the London market and the policy steps needed to support listed equity valuations.
For now, however, attention will remain firmly on Intertek itself. With shares surging and the board under fresh pressure, the coming weeks could prove decisive in determining whether one of the FTSE 100's more recognisable names follows the well-trodden path from public listing to private ownership.
Private equity context
EQT's renewed push for Intertek arrives at a moment when private equity firms across Europe and North America are once again pivoting towards public-to-private transactions. After a quieter period dominated by smaller bolt-on deals, several of the largest sponsors have signalled growing appetite for sizeable take-privates, particularly where they believe public-market valuations have failed to keep pace with underlying Earnings power.
The Swedish house is no stranger to large transactions. Over the past decade it has built a reputation for buying high-quality businesses in technical services, industrial software and healthcare, and for backing management teams to invest in operational improvements and digital transformation programmes. Industry observers note that Intertek's portfolio of laboratories, customer relationships and assurance services fits squarely within EQT's stated Investment thesis, particularly its focus on businesses with structural growth tailwinds.
Debt-financing conditions have also become more accommodating in recent quarters. Spreads on leveraged loans have tightened from their peaks, and the high-Yield market is once again receptive to large deals, particularly those involving cash-generative businesses with diversified end markets. That backdrop helps explain the willingness of sponsors to revisit ambitious targets that had appeared out of reach during the more constrained financing environment of the past two years.
Regulatory and political angles
Any deal of this size in the UK would also need to navigate a complex regulatory landscape. The Competition and Markets Authority would be expected to take an interest, particularly given the cross-sector implications of the testing and inspection industry. Industry experts believe that, given Intertek's relatively fragmented market and the presence of similarly large global competitors, antitrust concerns are unlikely to derail a transaction, although carve-outs cannot be ruled out.
On the political side, there has been increasing focus on the implications of overseas takeovers of large UK-listed companies. Recent governments have shown a willingness to scrutinise transactions through the National Security and Investment Act, especially where critical national infrastructure or sensitive technology is concerned. Although Intertek's services are not believed to fall squarely into the most sensitive categories, advisers acknowledge that a careful approach to regulatory engagement will be essential to any successful bid process.






Please wait processing your request...